Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Riess

Showing results (201-210 of 313) with videos related to

Pageof 32
Sort By:
Human Molecular Genetics|June 18, 2005
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's diseaseKarsten M Strauss, L Miguel Martins, Helene Plun-Favreau, et al.
Journal of Huntington'S Disease|September 4, 2015
FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up StudyRalf Reilmann, Veronika Lippross, Eva Hölzner, et al.
Human Molecular Genetics|November 26, 2015
Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2Nicolas Casadei, Poonam Sood, Thomas Ulrich, et al.
Frontiers in Oncology|March 18, 2021
Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant MelanomaAndrea Forschner, Tobias Sinnberg, Gabi Mroz, et al.
Frontiers in Molecular Neuroscience|October 27, 2018
Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3Tina Harmuth, Caroline Prell-Schicker, Jonasz J Weber, et al.
Human Molecular Genetics|March 13, 2014
Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic miceMeike Diepenbroek, Nicolas Casadei, Hakan Esmer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 8, 2024
A Novel PINK1 p.F385S Loss-of-Function Mutation in an Indian Family with Parkinson's DiseaseKaran Sharma, Asha Kishore, Anna Lechado-Terradas, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Healthcare (Basel, Switzerland)|August 26, 2022
Meeting the Need for a Discussion of Unmet Medical NeedDenis Horgan, Bettina Borisch, Bogi Eliasen, et al.
Annals of Neurology|September 30, 2005
New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14Stephan Klebe, Alexandra Durr, Alexander Rentschler, et al.
Pageof 32

Showing results (201-210 of 313) with videos related to

Sort By:
Pageof 32
Human Molecular Genetics|June 18, 2005
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's diseaseKarsten M Strauss, L Miguel Martins, Helene Plun-Favreau, et al.
Journal of Huntington'S Disease|September 4, 2015
FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up StudyRalf Reilmann, Veronika Lippross, Eva Hölzner, et al.
Human Molecular Genetics|November 26, 2015
Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2Nicolas Casadei, Poonam Sood, Thomas Ulrich, et al.
Frontiers in Oncology|March 18, 2021
Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant MelanomaAndrea Forschner, Tobias Sinnberg, Gabi Mroz, et al.
Frontiers in Molecular Neuroscience|October 27, 2018
Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3Tina Harmuth, Caroline Prell-Schicker, Jonasz J Weber, et al.
Human Molecular Genetics|March 13, 2014
Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic miceMeike Diepenbroek, Nicolas Casadei, Hakan Esmer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 8, 2024
A Novel PINK1 p.F385S Loss-of-Function Mutation in an Indian Family with Parkinson's DiseaseKaran Sharma, Asha Kishore, Anna Lechado-Terradas, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Healthcare (Basel, Switzerland)|August 26, 2022
Meeting the Need for a Discussion of Unmet Medical NeedDenis Horgan, Bettina Borisch, Bogi Eliasen, et al.
Annals of Neurology|September 30, 2005
New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14Stephan Klebe, Alexandra Durr, Alexander Rentschler, et al.
Pageof 32